Effect of Hepatic or Renal Impairment on the Pharmacokinetics of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor
Devineni, Damayanthi, PhD, Curtin, Christopher R., BS, Marbury, Thomas C., MD, Smith, William, MD, FACC, Vaccaro, Nicole, BS, Wexler, David, BS, Vandebosch, An, PhD, Rusch, Sarah, MSc, Stieltjes, Hans, MSc, Wajs, Ewa, MD, PhD
Published in Clinical therapeutics (01.03.2015)
Published in Clinical therapeutics (01.03.2015)
Get full text
Journal Article